• BOYAJIAN, C.L. & LESLIE, F.M. (1987). Pharmacological evidence for alpha-2 adrenoceptor heterogeneity: Differential binding properties of [3H]rauwolscine and [3H]idazoxan in rat brain. J. Pharmacol. Exp. Ther., 241, 10921098.
  • BROADHURST, A.M., ALEXANDER, B.S. & WOOD, M.D. (1988). Heterogeneous [3H]rauwolscine binding sites in rat cortex: two alpha2-adrenoceptor subtypes or an additional non-adrenergic interaction. Life Sci., 43, 8392.
  • BYLUND, D.B. (1981). Comparison of [3H]clonidine and [3H]yohimbine binding: Possible subtypes of the alpha2-adrenergic receptors. Pharmacologist, 23, 215221.
  • BYLUND, D.B. (1985). Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav., 22, 835843.
  • BYLUND, D.B. (1988). Subtypes of alpha2-adrenoceptors: Pharmacological and molecular biological evidence converge. Trends Pharmacol. Sci., 9, 356361.
  • BYLUND, D.B., RAY-PRENGER, C. & MURPHY, T.J. (1988). Alpha-2A and alpha-2B adrenergic receptor subtypes: Antagonist binding in tissues and cell lines containing only one subtype. J. Pharmacol. Exp. Ther., 245, 600607.
  • CHENG, Y-C. & PRUSOFF, W.H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol., 22, 30993108.
  • CHEUNG, Y-D., BARNETT, D.B. & NAHORSKI, S.R. (1982). [3H]-rauwolscine and [3H]-yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha2- adrenoceptors. Eur. J. Pharmacol., 84, 7985.
  • COUPRY, I., PODEVIN, R.A., DAUSSE, J.P. & PARINI, A. (1987). Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney. Biochem. Biophys. Res. Commun., 147, 10551060.
  • DICKINSON, K.E.J., McKERNAN, R.M., MILES, C.M.M., LEYS, K.S. & SEVER, P.S. (1986). Heterogeneity of mammalian alpha2- adrenoceptors delineated by [3H]yohimbine binding. Eur. J. Pharmacol., 120, 285293.
  • DIOP, L., DAUSSE, J-P. & MEYER, P. (1983). Specific binding of [3H]rauwolscine to alpha2-adrenoceptors in rat cerebral cortex: Comparison between crude and synaptosomal plasma membranes. J. Neurochem., 41, 710715.
  • KAWAHARA, R.S. & BYLUND, D.B. (1985). Solubilization and characterization of putative alpha2-adrenergic isoreceptors from the human platelet and the rat cerebral cortex. J. Pharmacol. Exp. Ther., 233, 603610.
  • LATTIMER, N. & RHODES, K.F. (1985). A difference in the affinity of some selective alpha2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit. Naunyn Schmiedebergs Arch. Pharmacol., 329, 278281.
  • MELCHIORRE, C., BRASILI, L., GIARDINA, D. & PIGINI, M. (1984). 2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl]1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha1-adrenoreceptors. J. Med. Chem., 27, 15351536.
  • MICHEL, A.D. & WHITING, R.L. (1981). 2–2(-Imadozolyl methyl)-1,4-benzodioxans, a series of selective alpha2-adrenoceptor antagonists. Br. J. Pharmacol., 74, 255P.
  • MICHEL, A.D. & WHITING, R.L. (1984). Binding of [3H]-yohimbine in rat cerebral cortex. Br. J. Pharmacol., 81, 95P.
  • MICHEL, A.D. & WHITING, R.L. (1988). Methoctramine, a polymethylene tetraamine, differentiates three subtypes of muscarinic receptor in direct binding studies. Eur. J. Pharmacol., 145, 6166.
  • MICHEL, A.D., LOURY, D.N. & WHITING, R.L. (1989). Differences between the α2-adrenoceptor in rat submaxillary gland and the α2A- and α2B-adrenoceptor subtypes. Br. J. Pharmacol., 98, 890897.
  • MUNSON, P.J. & RODBARD, D. (1980). Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem., 107, 220239.
  • NEYLON, C.B. & SUMMERS, R.J. (1985). [2H]-rauwolscine binding to alpha2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species. Br. J. Pharmacol., 85, 349359.
  • REGAN, J.W., KOBILKA, T.S., YANG-FENG, T.L., CARON, M.G., LEFKOWITZ, R.J. & KOBILKA, B.K. (1988). Cloning and expression of a human kidney cDNA for an alpha2-adrenergic receptor subtype. Proc. Natl. Acad. Sci. U.S.A., 85, 63016305.
  • RUFFOLO, R.R., SULPIZIO, A.C., NICHOLS, A.J., DeMARINIS, R.M. & HIEBLE, J.P. (1988). Pharmacologic differentiaton between pre- and postjunctional alpha2-adrenoceptors by SK&F 104078. Naunyn-Schmiedebergs Arch. Pharmacol., 336, 415418.
  • SUMMERS, R.J., BARNETT, D.B. & NAHORSKI, S.R. (1983). The characteristics of adrenoceptors in homogenates of human cerebral cortex labeled by [3H]-rauwolscine. Life Sci., 33, 11051112.
  • TURNER, J.T., PIERCE, D.L. & BYLUND, D.B. (1984). Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-EC. Life Sci., 35, 13851394.